TY - JOUR AU - Riedlbauchová, Lucie; Durdil, Václav; Honěk, Jakub; Veselka, Josef TI - Nonpharmacological Treatment of Atrial Fibrillation: What Is the Role of Device Therapy? SN - 1061-1711 SN - 1615-5939 PY - 2020 JO - Int J Angiol JF - International Journal of Angiology LA - EN VL - 29 IS - 02 SP - 113 EP - 122 ET - 2020/04/28 DA - 2020/05/26 KW - atrial fibrillation KW - sick sinus syndrome KW - heart failure KW - cardiac pacing KW - cardiac resynchronization KW - ICD KW - AV junctional ablation AB - Atrial fibrillation is the most common arrhythmia in the adult population, and its incidence and prevalence are still rising. Cardiac devices are widely used in clinical practice in the management of various rhythm disturbances and heart failure treatment. Many patients who receive a pacemaker, implantable cardioverter-defibrillator, or cardiac resynchronization therapy also experience atrial fibrillation in the course of their life. Therefore, this review aims to describe the role of these devices in the treatment and prevention of atrial fibrillation in the device recipients. In addition, all these implantable devices also serve as permanent ECG (electrocardiogram) monitors, thus providing important information about the presence and characteristics of atrial fibrillation that may or may not be detected by the patient but can modify our therapeutical approach with regard to the stroke prevention. PB - Thieme Medical Publishers DO - 10.1055/s-0040-1708529 UR - http://www.thieme-connect.de/products/ejournals/abstract/10.1055/s-0040-1708529 ER -